Skip to main content


International Journal of Hematology

International Journal of Hematology OnlineFirst articles

14.02.2020 | Guideline

JSH practical guidelines for hematological malignancies, 2018: I. Leukemia-6 myelodysplastic syndromes (MDS)

Myelodysplastic syndromes (MDS) are myeloid neoplasms characterized by abnormal proliferation and apoptosis of hematopoietic cells that are believed to be caused by abnormalities in immature hematopoietic cells [1, 2]. The concept of MDS was first …

13.02.2020 | Original Article

Metabolomics analysis identifies lysine and taurine as candidate prognostic biomarkers for AML-M2 patients

There is an ongoing search for potential biomarkers for acute myeloid leukemia (AML) patients using metabolic analysis. However, only few studies to date have focused on bone marrow samples or a specific subtype of AML. In the present study, we …

12.02.2020 | Original Article

Impact of graft-versus-host disease on the clinical outcome of allogeneic hematopoietic stem cell transplantation for non-malignant diseases

The impact of acute and chronic graft-versus-host disease (GVHD) on clinical outcomes was retrospectively analyzed in 960 patients with non-malignant diseases (NMD) who underwent a first allogeneic hematopoietic stem cell transplantation (HSCT).

07.02.2020 | Progress in Hematology

Clinical value of measurable residual disease testing for multiple myeloma and implementation in Japan

The development of novel therapeutic agents has led to an increase in patients with multiple myeloma (MM) who achieve a complete response (CR). Consequently, a good correlation has been established between the CR rate and progression-free …

06.02.2020 | Progress in Hematology

Molecular basis of clonal evolution in multiple myeloma

The treatment outcome of multiple myeloma (MM) is worse than expected from the average numbers of non-synonymous mutations, which are roughly correlated with the prognosis of cancer patients. The refractoriness of MM may be ascribed to the complex …

Aktuelle Ausgaben

Über diese Zeitschrift

This official journal of the Japanese Society of Hematology covers all aspects of the field of hematology, namely, erythrocytes, leukocytes and hematopoiesis, hemostasis, thrombosis and vascular biology, hematological malignancies, transplantation, and cell therapy.

The International Journal of Hematology has a long history of publishing leading research in the field. It features articles that contribute to progress in research not only in basic hematology but also in clinical hematology. The expanded Progress in Hematology section integrates such relevant fields as the cell biology of stem cells and cancer cells, and clinical research in inflammation, cancer, and thrombosis. In addition, the journal includes reports on results of clinical trials, which help foster communication among researchers in the growing field of modern hematology.

The journal provides the best of up-to-date information on modern hematology, presenting readers with high-impact, original work focusing on pivotal issues.

Color figures are free in print and online.

Weitere Informationen

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.